{"schema_version":"1","generated_at":"2026-10-29T20:43:14.827Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mariya-rozenblit","json_url":"https://www.findmykol.com/kol/mariya-rozenblit/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mariya-rozenblit","name":"Mariya Rozenblit","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Yale University","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1215315015","orcid":"0000-0002-8874-6688","openalex":"A5036717695"},"summary":"Mariya Rozenblit is an Oncology physician affiliated with Yale University. OpenAlex indexes 39 publications with 1,522 citations (h-index 14); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":39,"cited_by_count":1522,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07578116","title":"Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis","phase":"PHASE3","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT07578116","trial_url":"https://www.findmykol.com/trial/NCT07578116"},{"nct":"NCT06923527","title":"Circulating Tumor DNA","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT06923527","trial_url":"https://www.findmykol.com/trial/NCT06923527"},{"nct":"NCT06572800","title":"Tka Assay for CDK4/6i","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT06572800","trial_url":"https://www.findmykol.com/trial/NCT06572800"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":2200,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215315015"},{"payer":"Caris MPI, Inc.","program_year":2025,"amount_usd":37.1,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215315015"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":3355,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215315015"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215315015","source":"payments"},"publications":{"total":40,"shown":5,"withheld":35,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract RF5-06: Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788: Results from the I-SPY2.2 trial","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-rf5-06","status":"verified"},{"title":"Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers","year":2025,"journal":"Cancer Medicine","source_url":"https://doi.org/10.1002/cam4.70929","status":"verified"},{"title":"Abstract P4-03-29: Patient reported anxiety levels during ctDNA surveillance in early stage triple negative and hormone positive breast cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p4-03-29","status":"verified"},{"title":"Quantifying the clinical impact of tissue reflex testing for liquid biopsy <i>ESR1</i> mutation–negative cases with low ctDNA tumor fraction (TF) in HR(+)HER2(-) breast cancer.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1065","status":"verified"},{"title":"Abstract P2-03-27: Prevalence of actionable genomic alterations (GA) and predictive value of tumor mutational burden (TMB) for immune checkpoint inhibitor (ICI) effectiveness in HR(+)HER2(-) metastatic breast cancer (MBC)","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-p2-03-27","status":"verified"}],"source":"works"},"contact":{"address_1":"333 CEDAR ST","city":"New Haven","state":"CT","zip":"065103206","phone":"203-688-4242","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1215315015","source":"identity"},"similar":[{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"},{"name":"Lajos Pusztai","slug":"lajos-pusztai","institution":"Yale University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/lajos-pusztai","json_url":"https://www.findmykol.com/kol/lajos-pusztai/profile.json"},{"name":"Lee Schwamm","slug":"lee-schwamm","institution":"Yale University","specialty":"Neurology","url":"https://www.findmykol.com/kol/lee-schwamm","json_url":"https://www.findmykol.com/kol/lee-schwamm/profile.json"},{"name":"Thomas McGlashan","slug":"thomas-mcglashan","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/thomas-mcglashan","json_url":"https://www.findmykol.com/kol/thomas-mcglashan/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":35}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-06-11","provider_certified":"2021-06-11","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}